Representative before the EPO

Technology company logo thumb
no operation time available
3 offices
Technology Company

Representative before the EPO

Employment test 201 - 500 employees
Company dna awapatent
operating since 1897
1316.08
AWA
Headquarter in Malmö and 16 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

We have observed 20 EP applications Tomas Lundquist has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after September 22, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12710277

NOVEL PYRIMIDINE DERIVATIVES

IPC classification:
A61K 31/506, C07D 403/14, A61P 35/00
Agent:
Tomas Lundquist, AWA
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12718949

LYOPHILIZED PREPARATION OF CYTOTOXIC DIPEPTIDES

IPC classification:
A61K 47/26, A61K 47/12, A61K 38/05, F26B 5/06, A61P 35/00
Agent:
Abel & Imray
Agent:
Tomas Lundquist, AWA
Status:
The patent has been granted
EP12183264

Tiotropium preparations

IPC classification:
A61K 31/46, A61K 9/16, A61K 9/14, A61K 9/00, C07D 451/10
Agent:
Tomas Lundquist, AWA
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12185465

4-Indazolylamino-2-(2-(indol-3-yl)ethyl)aminopyrimidines useful for the treatment of cancer

IPC classification:
A61K 31/506, C07D 403/14, A61P 37/00, A61P 35/00, A61P 33/00, A61P 31/00, A61P 29/00
Agent:
Tomas Lundquist, AWA
Status:
GRANT OF PATENT INTENDED
EP12185460

4-(Indolyl or benzimidazolyl)amino-2-(2-(indol-3-yl)ethyl)aminopyrimidines useful for the treatment of cancer

IPC classification:
A61K 31/506, C07D 403/14, A61P 37/00, A61P 35/00, A61P 33/00, A61P 31/00, A61P 29/00
Agent:
Tomas Lundquist, AWA
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12835172

IMPROVED FORMULATIONS OF RECOMBINANT HUMAN BILE SALT-STIMULATED LIPASE

IPC classification:
A61K 38/46, A61K 9/19, A23C 9/152, C12N 9/18
Agent:
Tomas Lundquist, AWA
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12779278

TREATMENT OF PSORIASIS

IPC classification:
A61K 47/24, A61K 31/593, A61K 31/573, A61K 8/58, A61P 17/06
Agent:
Tomas Lundquist, AWA
Agent:
Maria Malmqvist, Conimar AB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12790904

METHOD FOR PREVENTION OF COLECTOMY

IPC classification:
A61K 48/00, A61P 37/00
Agent:
Ravi Chandran Srinivasan, J A Kemp
Agent:
Tomas Lundquist, AWA
Status:
GRANT OF PATENT INTENDED
EP14154304

The use of pregnane and androstane steroids for the manufacture of a pharmaceutical composition for the treatment of cns disorders

IPC classification:
A61K 31/57, A61K 31/5685, A61K 31/568, C07J 41/00, C07J 7/00, C07J 1/00, A61P 25/28, A61P 25/10, A61P 25/00
Agent:
Tomas Lundquist, AWA
Status:
PATENT GRANTED
EP13198608

The use of pregnane and androstane steroids for the manufacture of a pharmaceutical composition for the treatment of CNS disorders

IPC classification:
A61K 31/57, A61K 31/5685, A61K 31/568, C07J 41/00, C07J 7/00, C07J 1/00, A61P 25/28, A61P 25/10, A61P 25/00
Agent:
Tomas Lundquist, AWA
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13198584

The use of pregnane and androstane steroids for the manufacture of a pharmaceutical composition for the treatment of CNS disorders

IPC classification:
A61K 31/57, A61K 31/5685, A61K 31/568, C07J 41/00, C07J 7/00, C07J 1/00, A61P 25/28, A61P 25/10, A61P 25/00
Agent:
Groth & Co KB
Agent:
Tomas Lundquist, AWA
Status:
The patent has been granted
EP12774040

LIQUID CARRIER FOR ORAL DELIVERY OF A PHARMACOLOGICALLY ACTIVE AGENT

IPC classification:
A61K 47/44, A61K 47/34, A61K 9/48, A61K 9/28, A61K 9/20, A61K 9/10
Agent:
Tomas Lundquist, AWA
Agent:
Maria Malmqvist, Conimar AB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13736318

A METHOD FOR PRODUCING STABLE, AMORPHOUS HYBRID NANOPARTICLES COMPRISING AT LEAST ONE PROTEIN KINASE INHIBITOR AND AT LEAST ONE POLYMERIC STABILIZING AND MATRIX- FORMING COMPONENT.

IPC classification:
A61K 47/38, A61K 47/34, A61K 47/32, A61K 31/517, A61K 31/506, A61K 9/14
Agent:
Groth & Co KB
Agent:
Tomas Lundquist, AWA
Status:
EXAMINATION IN PROGRESS
EP13736055

A PHARMACEUTICAL COMPOSITION COMPRISING STABLE, AMORPHOUS HYBRID NANOPRATICLES OF AT LEAST ONE PROTEIN KINASE INHIBITOR AND AT LEAST ONE POLYMERIC STABILIZING AND MATRIX-FORMING COMPONENT

IPC classification:
A61K 47/38, A61K 47/34, A61K 47/32, A61K 31/517, A61K 31/506, A61K 9/51, A61K 9/14, A61P 35/00
Agent:
Tomas Lundquist, AWA
Status:
EXAMINATION IN PROGRESS
EP12785836

LOW PH PROTEIN PURIFICATION PROCESS

IPC classification:
C12N 9/20, C12N 9/18, C07K 1/20, C07K 1/18, B01D 15/36, B01D 15/32
Agent:
Tomas Lundquist, AWA
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12860641

NUT FOR A DENTAL IMPLANT

IPC classification:
A61C 8/00
Agent:
Tomas Lundquist, AWA
Status:
GRANT OF PATENT INTENDED
EP12178275

Handheld device for use during exercise

IPC classification:
A63B 71/06, A63B 69/00, A63B 24/00, A63B 21/00
Applicant:
Salong Edsviken AB
Agent:
Tomas Lundquist, AWA
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13765361

4-(INDOLYL OR BENZIMIDAZOLYL)AMINO-2-(2-(INDOL-3-YL)ETHYL)AMINOPYRIMIDINES USEFUL FOR THE TREATMENT OF CANCER

IPC classification:
A61K 31/506, C07D 403/14, A61P 37/00, A61P 35/00, A61P 33/00, A61P 31/00, A61P 29/00
Agent:
Tomas Lundquist, AWA
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13765360

4-INDAZOLYLAMINO-2-(2-(INDOL-3-YL)ETHYL)AMINOPYRIMIDINES USEFUL FOR THE TREATMENT OF CANCER

IPC classification:
A61K 31/506, C07D 403/14, A61P 37/00, A61P 35/00, A61P 33/00, A61P 31/00, A61P 29/00
Agent:
Tomas Lundquist, AWA
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13849763

LYOPHILIZED PREPARATIONS OF MELPHALAN FLUFENAMIDE

IPC classification:
A61K 47/26, A61K 31/216, A61K 9/19, A61P 35/00
Agent:
Abel & Imray
Agent:
Tomas Lundquist, AWA
Status:
GRANT OF PATENT INTENDED

Please Sign in to use this feature